Literature DB >> 7731995

Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector.

K Mitani1, F L Graham, C T Caskey, S Kochanek.   

Abstract

Adenoviral vectors are widely used as highly efficient gene transfer vehicles in a variety of biological research strategies including human gene therapy. One of the limitations of the currently available adenoviral vector system is the presence of the majority of the viral genome in the vector, resulting in leaky expression of viral genes particularly at high multiplicity of infection and limited cloning capacity of exogenous sequences. As a first step to overcome this problem, we attempted to rescue a defective human adenovirus serotype 5 DNA, which had an essential region of the viral genome (L1, L2, VAI + II, pTP) deleted and replaced with an indicator gene. In the presence of wild-type adenovirus as a helper, this DNA was packaged and propagated as transducing viral particles. After several rounds of amplification, the titer of the recombinant virus reached at least 4 x 10(6) transducing particles per ml. The recombinant virus could be partially purified from the helper virus by CsCl equilibrium density-gradient centrifugation. The structure of the recombinant virus around the marker gene remained intact after serial propagation, while the pBR sequence inserted in the E1 region was deleted from the recombinant virus. Our results suggest that it should be possible to develop a helper-dependent adenoviral vector, which does not encode any viral proteins, as an alternative to the currently available adenoviral vector systems.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731995      PMCID: PMC42060          DOI: 10.1073/pnas.92.9.3854

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Enhanced infectivity of adenovirus type 2 DNA and a DNA-protein complex.

Authors:  G Chinnadurai; S Chinnadurai; M Green
Journal:  J Virol       Date:  1978-04       Impact factor: 5.103

2.  The structure and expression of two defective adenovirus 2/simian virus 40 hybrids.

Authors:  J A Hassell; E Lukanidin; G Fey; J Sambrook
Journal:  J Mol Biol       Date:  1978-04-05       Impact factor: 5.469

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

4.  Palindromic adenovirus type 5-simian virus 40 hybrid.

Authors:  Y Gluzman; K Van Doren
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

5.  Proof of recombination between viral and cellular genomes in human KB cells productively infected by adenovirus type 12: structure of the junction site in a symmetric recombinant (SYREC).

Authors:  R Deuring; W Doerfler
Journal:  Gene       Date:  1983-12       Impact factor: 3.688

Review 6.  Uptake, fixation, and expression of foreign DNA in mammalian cells: the organization of integrated adenovirus DNA sequences.

Authors:  W Doerfler
Journal:  Curr Top Microbiol Immunol       Date:  1982       Impact factor: 4.291

7.  Replication of adenovirus mini-chromosomes.

Authors:  R T Hay; N D Stow; I M McDougall
Journal:  J Mol Biol       Date:  1984-06-05       Impact factor: 5.469

8.  Encapsidation of adenovirus 16 DNA is directed by a small DNA sequence at the left end of the genome.

Authors:  M L Hammarskjöld; G Winberg
Journal:  Cell       Date:  1980-07       Impact factor: 41.582

9.  An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

Authors:  A J Bett; W Haddara; L Prevec; F L Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

10.  An unusual symmetric recombinant between adenovirus type 12 DNA and human cell DNA.

Authors:  R Deuring; G Klotz; W Doerfler
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more
  62 in total

1.  Frequency and stability of chromosomal integration of adenovirus vectors.

Authors:  A Harui; S Suzuki; S Kochanek; K Mitani
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Optimization of the helper-dependent adenovirus system for production and potency in vivo.

Authors:  V Sandig; R Youil; A J Bett; L L Franlin; M Oshima; D Maione; F Wang; M L Metzker; R Savino; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector.

Authors:  A Recchia; R J Parks; S Lamartina; C Toniatti; L Pieroni; F Palombo; G Ciliberto; F L Graham; R Cortese; N La Monica; S Colloca
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

4.  Episomal segregation of the adenovirus enhancer sequence by conditional genome rearrangement abrogates late viral gene expression.

Authors:  X Wang; W Zeng; M Murakawa; M W Freeman; B Seed
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer.

Authors:  M Hillgenberg; H Tönnies; M Strauss
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector.

Authors:  Shuji Kubo; Kohnosuke Mitani
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 7.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

8.  E1A and E1B proteins inhibit inflammation induced by adenovirus.

Authors:  Jerome Schaack; Michael L Bennett; Jeff D Colbert; Andres Vazquez Torres; Gerald H Clayton; David Ornelles; John Moorhead
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

9.  Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors.

Authors:  Emi Aizawa; Yuka Hirabayashi; Yuzuru Iwanaga; Keiichiro Suzuki; Kenji Sakurai; Miho Shimoji; Kazuhiro Aiba; Tamaki Wada; Norie Tooi; Eihachiro Kawase; Hirofumi Suemori; Norio Nakatsuji; Kohnosuke Mitani
Journal:  Mol Ther       Date:  2011-12-06       Impact factor: 11.454

Review 10.  Cocaine hydrolase gene therapy for cocaine abuse.

Authors:  Stephen Brimijoin; Yang Gao
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.